ANI Pharmaceuticals Inc (NAS:ANIP)
$ 54.41 -1.09 (-1.96%) Market Cap: 1.14 Bil Enterprise Value: 1.64 Bil PE Ratio: 0 PB Ratio: 2.82 GF Score: 85/100

Q3 2021 ANI Pharmaceuticals Inc Earnings Call Transcript

Nov 01, 2021 / 12:30PM GMT
Release Date Price: $55.89 (+49.52%)
Operator

Good day, everyone, and welcome to ANI Pharmaceuticals' Third Quarter 2021 Earnings Results Call. (Operator Instructions) Please note, this call is being recorded. It is now my pleasure to turn the program over to Lisa Wilson.

Lisa Wilson

Thank you, Emma. Welcome to ANI Pharmaceuticals' Q3 2021 Earnings Results Call. This is Lisa Wilson, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com.

Before we get started, I would like to remind everyone that any statement made on today's conference call that expresses a belief, expectation, projection, forecast, anticipation or intent regarding future events and the company's future performance may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are based on information available to ANI Pharmaceuticals

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot